{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:46:08Z","timestamp":1780731968293,"version":"3.54.1"},"reference-count":352,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuint.2026.106161","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:31:57Z","timestamp":1776814317000},"page":"106161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-0311","authenticated-orcid":false,"given":"Geoffrey E.","family":"Woodard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1996.0043","article-title":"Localization and cell association of C1q in Alzheimer's disease brain","volume":"138","author":"Afagh","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2026.106161_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2015.00417","article-title":"Complement in the homeostatic and ischemic brain","volume":"6","author":"Alawieh","year":"2015","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1523\/JNEUROSCI.2197-17.2018","article-title":"Identifying the role of complement in triggering neuroinflammation after traumatic brain injury","volume":"38","author":"Alawieh","year":"2018","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-4159.2008.05668.x","article-title":"The complement cascade: Yin-yang in neuroinflammation \u2013 neuro-protection and -degeneration","volume":"107","author":"Alexander","year":"2008","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.1200409","article-title":"Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA","volume":"189","author":"Allen","year":"2012","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib6","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.neuint.2026.106161_bib7","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","article-title":"Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Apolloni","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","article-title":"Complement activation in experimental and human temporal lobe epilepsy","volume":"26","author":"Aronica","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2026.106161_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.neuroscience.2008.07.015","article-title":"Neuroprotection in stroke by complement inhibition and immunoglobulin therapy","volume":"158","author":"Arumugam","year":"2009","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.neuint.2026.106161_bib11","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"issue":"Pt 2","key":"10.1016\/j.neuint.2026.106161_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awn334","article-title":"Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signaling","volume":"132","author":"Baer","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"22","key":"10.1016\/j.neuint.2026.106161_bib14","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2013","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib15","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1074\/jbc.M109.092106","article-title":"The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction","volume":"285","author":"Bamberg","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1\u20133","key":"10.1016\/j.neuint.2026.106161_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","article-title":"A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis","volume":"47","author":"Barbeito","year":"2004","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib20","first-page":"265","article-title":"Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury","volume":"184","author":"Bellander","year":"2011","journal-title":"Exp. Brain Res."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/08977150152725605","article-title":"Complement activation in the human brain after traumatic head injury","volume":"18","author":"Bellander","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"21","key":"10.1016\/j.neuint.2026.106161_bib22","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1523\/JNEUROSCI.3981-16.2017","article-title":"Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex","volume":"37","author":"Bellesi","year":"2017","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.neuint.2026.106161_bib23","first-page":"11232","article-title":"Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation","volume":"283","author":"Benard","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7\u20138","key":"10.1016\/j.neuint.2026.106161_bib24","first-page":"538","article-title":"Neurofilaments in pre-symptomatic ALS and the impact of genotype","volume":"20","author":"Benatar","year":"2018","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib27","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.4049\/jimmunol.173.11.6921","article-title":"Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex","volume":"173","author":"Bossi","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2009.09.001","article-title":"Immune proteins in brain development and synaptic plasticity","volume":"64","author":"Boulanger","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2026.106161_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1742-2094-9-137","article-title":"Complement activation in the injured central nervous system: another dual-edged sword?","volume":"9","author":"Brennan","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"16","key":"10.1016\/j.neuint.2026.106161_bib31","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib32","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.165.7.3999","article-title":"Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack","volume":"165","author":"Brodbeck","year":"2000","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bdi.12422","article-title":"Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance","volume":"18","author":"Burghardt","year":"2016","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/0960327102ht217oa","article-title":"Defining hormesis","volume":"21","author":"Calabrese","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib35","first-page":"895","article-title":"Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance","volume":"26","author":"Calabrese","year":"2008","journal-title":"Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib36","first-page":"245","article-title":"Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes","volume":"18","author":"Calabrese","year":"2004","journal-title":"In Vivo"},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib37","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s11064-008-9775-9","article-title":"Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity","volume":"33","author":"Calabrese","year":"2008","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib39","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/ars.2009.3074","article-title":"Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders","volume":"13","author":"Calabrese","year":"2010","journal-title":"Antioxid. Redox Signaling"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4049\/jimmunol.166.2.723","article-title":"Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice","volume":"166","author":"Calida","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson's disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"46","key":"10.1016\/j.neuint.2026.106161_bib45","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Pt 10","key":"10.1016\/j.neuint.2026.106161_bib46","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib47","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","article-title":"Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration","volume":"11","author":"Choi","year":"2020","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.neuint.2026.106161_bib48","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuint.2026.106161_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2020.00274","article-title":"The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation","volume":"14","author":"Comer","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"9648","key":"10.1016\/j.neuint.2026.106161_bib50","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2990.1989.tb01231.x","article-title":"Immunocytochemical localization of the terminal complement complex in multiple sclerosis","volume":"15","author":"Compston","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.04070.x","article-title":"Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis","volume":"159","author":"Copland","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2006.05.029","article-title":"Role of complement component C5 in cerebral ischemia\/reperfusion injury","volume":"1100","author":"Costa","year":"2006","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib55","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.1403068","article-title":"Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth","volume":"194","author":"Coulthard","year":"2015","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.neuint.2026.106161_bib56","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1523\/JNEUROSCI.0525-17.2017","article-title":"Complement C5aR1 signaling promotes polarization and proliferation of embryonic neural progenitor cells through PKC\u03b6","volume":"37","author":"Coulthard","year":"2017","journal-title":"J. Neurosci."},{"issue":"28","key":"10.1016\/j.neuint.2026.106161_bib57","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1523\/JNEUROSCI.23-28-09459.2003","article-title":"Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats","volume":"23","author":"Cowell","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106161_bib58","article-title":"Microglia, Alzheimer's disease, and complement","volume":"2012","author":"Crehan","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.immuni.2016.02.013","article-title":"Microglial physiology and pathophysiology: insights from genome-wide transcriptional profiling","volume":"44","author":"Crotti","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib60","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer's disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease","volume":"119","author":"Daborg","year":"2012","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \"dying-back\" phenomenon of motor neurons in ALS","volume":"43","author":"Dadon-Nachum","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib65","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2017","journal-title":"Lancet Neurol."},{"issue":"13","key":"10.1016\/j.neuint.2026.106161_bib67","first-page":"2061","article-title":"Human traumatic brain injury induces complement C5a synthesis","volume":"36","author":"De Blasio","year":"2019","journal-title":"J. Neurotrauma"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib68","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ajhg.2011.05.011","article-title":"Disease-causing mutations in genes of the complement system","volume":"88","author":"Degn","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib69","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib71","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(16)30158-2","article-title":"Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"Pt B","key":"10.1016\/j.neuint.2026.106161_bib72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","article-title":"The emerging role of Nrf2 in mitochondrial function","volume":"88","author":"Dinkova-Kostova","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib73","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jnr.24478","article-title":"Annexin A1 attenuates neuroinflammation through FPR2\/p38\/COX-2 pathway after intracerebral hemorrhage in male mice","volume":"98","author":"Ding","year":"2020","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib74","article-title":"Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke","volume":"4","author":"Ducruet","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12471","article-title":"Dangerous liaisons: complement, coagulation, and kallikrein\/kinin cross-talk act as a linchpin in the events leading to thromboinflammation","volume":"274","author":"Ekdahl","year":"2016","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1474-4422(04)00906-8","article-title":"Chronic epilepsy and cognition","volume":"3","author":"Elger","year":"2004","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib78","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1201904","article-title":"The alternative complement pathway propagates inflammation and injury in murine ischemic stroke","volume":"189","author":"Elvington","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib79","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","article-title":"Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk","volume":"71","author":"Eraly","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib80","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrn3978","article-title":"Immune mediators in the brain and peripheral tissues in autism spectrum disorder","volume":"17","author":"Estes","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"6301","key":"10.1016\/j.neuint.2026.106161_bib81","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.aag3194","article-title":"Maternal immune activation: implications for neuropsychiatric disorders","volume":"353","author":"Estes","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106161_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","article-title":"Inflammation and neurovascular changes in amyotrophic lateral sclerosis","volume":"53","author":"Evans","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"32","key":"10.1016\/j.neuint.2026.106161_bib83","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1523\/JNEUROSCI.0416-14.2014","article-title":"Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus","volume":"34","author":"Eyo","year":"2014","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.neuint.2026.106161_bib84","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1161\/01.CIR.0000160851.41872.C6","article-title":"Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia\/reperfusion injury","volume":"111","author":"Fan","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib85","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4049\/jimmunol.173.1.360","article-title":"Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP","volume":"173","author":"Fang","year":"2004","journal-title":"J. Immunol."},{"issue":"Pt 6","key":"10.1016\/j.neuint.2026.106161_bib86","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","article-title":"Disease-specific molecular events in cortical multiple sclerosis lesions","volume":"136","author":"Fischer","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib87","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","article-title":"Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice","volume":"192","author":"Fluiter","year":"2014","journal-title":"J. Immunol."},{"issue":"29","key":"10.1016\/j.neuint.2026.106161_bib89","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease","volume":"24","author":"Fonseca","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib90","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib91","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.15252\/embj.201593673","article-title":"Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode","volume":"35","author":"Forneris","year":"2016","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib92","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/glia.22331","article-title":"Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar A\u03b2 by microglia","volume":"60","author":"Fu","year":"2012","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib93","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.it.2004.04.008","article-title":"Structure and activation of the C1 complex of complement: unraveling the puzzle","volume":"25","author":"Gaboriaud","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainres.2009.04.047","article-title":"Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage","volume":"1298","author":"Garrett","year":"2009","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib95","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2026.106161_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"issue":"80","key":"10.1016\/j.neuint.2026.106161_bib97","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2023.2851","article-title":"Efficacy and safety of ravulizumab, a complement C5 inhibitor, in adults with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"1","author":"Genge","year":"2023","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-010-0439-6","article-title":"Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review","volume":"32","author":"Giordana","year":"2011","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib99","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease","volume":"342","author":"Goldknopf","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib101","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2026.106161_bib102","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2013.10.026","article-title":"Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy","volume":"62","author":"Gorter","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","article-title":"Complement driven by conformational changes","volume":"8","author":"Gros","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib104","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1074\/mcp.M114.038554","article-title":"In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)","volume":"13","author":"Guldbrandsen","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neuint.2026.106161_bib105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"5844","key":"10.1016\/j.neuint.2026.106161_bib106","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.1147103","article-title":"Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense","volume":"317","author":"Hadders","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12467","article-title":"More than complementing tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation","volume":"274","author":"Hajishengallis","year":"2016","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib108","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2004.10.024","article-title":"Classical pathway complement activity in schizophrenia","volume":"374","author":"Hakobyan","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib109","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11920-013-0387-y","article-title":"Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications","volume":"15","author":"Hamdani","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib111","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib112","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib113","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","article-title":"The alternative complement pathway revisited","volume":"12","author":"Harboe","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib114","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.2004.02627.x","article-title":"The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation","volume":"138","author":"Harboe","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"31","key":"10.1016\/j.neuint.2026.106161_bib115","first-page":"E6370","article-title":"Properdin binding to complement activating surfaces depends on initial C3b deposition","volume":"114","author":"Harboe","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuint.2026.106161_bib116","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuint.2026.106161_bib117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2026.106161_bib118","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/bj3410821","article-title":"Molecular and functional analysis of mouse decay accelerating factor (CD55)","volume":"341","author":"Harris","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2026.106161_bib119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.seizure.2017.02.017","article-title":"Epilepsy and cognition - a bidirectional relationship?","volume":"49","author":"Helmstaedter","year":"2017","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib121","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7434","key":"10.1016\/j.neuint.2026.106161_bib122","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib123","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib124","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1528-1167.2010.02952.x","article-title":"Combined analysis of risk factors for SUDEP","volume":"52","author":"Hesdorffer","year":"2011","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"10.1016\/j.neuint.2026.106161_bib125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib126","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib127","first-page":"2663","article-title":"Therapeutic complement inhibition: opportunities and challenges","volume":"105","author":"H\u00f6chsmann","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib128","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/epd.2015.0739","article-title":"Cognitive impairment in epilepsy: the role of network abnormalities","volume":"17","author":"Holmes","year":"2015","journal-title":"Epileptic Disord."},{"issue":"6286","key":"10.1016\/j.neuint.2026.106161_bib131","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib132","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis","volume":"12","author":"Hooten","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"10.1016\/j.neuint.2026.106161_bib133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0162-3109(00)80296-9","article-title":"Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1","volume":"49","author":"Hourcade","year":"2000","journal-title":"Immunopharmacology"},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib134","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib135","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1474-4422(23)00080-7","article-title":"Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study","volume":"22","author":"Howard","year":"2023","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib136","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/NEN.0b013e3181f3a5b1","article-title":"Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis","volume":"69","author":"Howell","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib137","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"5427","key":"10.1016\/j.neuint.2026.106161_bib138","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.285.5427.595","article-title":"Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein","volume":"285","author":"Huang","year":"1999","journal-title":"Science"},{"issue":"15\u201316","key":"10.1016\/j.neuint.2026.106161_bib139","first-page":"604","article-title":"Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia","volume":"86","author":"Hwang","year":"2010","journal-title":"Life Sci."},{"issue":"Pt 6","key":"10.1016\/j.neuint.2026.106161_bib140","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/brain\/awq085","article-title":"Complement regulator factor H as a serum biomarker of multiple sclerosis disease state","volume":"133","author":"Ingram","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106161_bib141","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2051-5960-2-53","article-title":"Complement activation in multiple sclerosis plaques: an immunohistochemical analysis","volume":"2","author":"Ingram","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib142","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1038\/s41467-018-07524-z","article-title":"Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies","volume":"9","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib143","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ajhg.2013.04.019","article-title":"Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls","volume":"92","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"7784","key":"10.1016\/j.neuint.2026.106161_bib144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer's disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib146","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.181.5.2953","article-title":"Comparative functional evolution of human and mouse CR1 and CR2","volume":"181","author":"Jacobson","year":"2008","journal-title":"J. Immunol."},{"issue":"7116","key":"10.1016\/j.neuint.2026.106161_bib147","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","article-title":"Structure of C3b reveals conformational changes that underlie complement activity","volume":"444","author":"Janssen","year":"2006","journal-title":"Nature"},{"issue":"7058","key":"10.1016\/j.neuint.2026.106161_bib148","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity","volume":"437","author":"Janssen","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib149","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib150","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.152.10.5050","article-title":"\u03b2-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain","volume":"152","author":"Jiang","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.expneurol.2012.01.013","article-title":"Axonal pathology in traumatic brain injury","volume":"246","author":"Johnson","year":"2013","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib152","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/jcbfm.1995.107","article-title":"Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats","volume":"15","author":"Kaczorowski","year":"1995","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2012.12.023","article-title":"Microglia: new roles for the synaptic stripper","volume":"77","author":"Kettenmann","year":"2013","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib156","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"9769","key":"10.1016\/j.neuint.2026.106161_bib157","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.neuint.2026.106161_bib158","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib159","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1227\/01.NEU.0000335079.70222.8D","article-title":"Protective effect of C5a receptor inhibition after murine reperfused stroke","volume":"63","author":"Kim","year":"2008","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2004.08.006","article-title":"C1q and tumor necrosis factor superfamily: modularity and versatility","volume":"25","author":"Kishore","year":"2004","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib161","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"K\u00f6hler","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2026.106161_bib162","first-page":"61","article-title":"Complement system biomarkers in first episode psychosis","volume":"233","author":"Kopczynska","year":"2021","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib163","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","article-title":"Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production","volume":"17","author":"Kossmann","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib164","first-page":"907","article-title":"Cerebrospinal fluid proteomics in multiple sclerosis","volume":"1865","author":"Kroksveen","year":"2017","journal-title":"Biochimica et Biophysica Acta - Proteins and Proteomics"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib166","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib168","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12035-023-03559-6","article-title":"Nrf2 signaling pathway: a potential therapeutic target in combating oxidative stress and neurotoxicity in chemotherapy-induced cognitive impairment","volume":"61","author":"Lal","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib169","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib171","first-page":"14","article-title":"Complement C3 from astrocytes plays significant roles in sustained activation of microglia and cognitive dysfunctions triggered by systemic inflammation after laparotomy in adult male mice","volume":"19","author":"Li","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib172","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.neuint.2026.106161_bib173","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106161_bib174","article-title":"Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies","volume":"16","author":"Lopez","year":"2025","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib176","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1300489","article-title":"Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1\u03b2 release","volume":"191","author":"Laudisi","year":"2013","journal-title":"J. Immunol."},{"issue":"Pt 7","key":"10.1016\/j.neuint.2026.106161_bib177","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","article-title":"Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits","volume":"123","author":"Lawrence","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106161_bib178","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101340","article-title":"Complement dysregulation in the central nervous system during development and disease","volume":"45","author":"Lee","year":"2019","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib182","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.expneurol.2006.01.033","article-title":"Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury","volume":"199","author":"Leinhase","year":"2006","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib183","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1523\/JNEUROSCI.1268-12.2013","article-title":"Microglia are essential to masculinization of brain and behavior","volume":"33","author":"Lenz","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","article-title":"Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS","volume":"237","author":"Liao","year":"2012","journal-title":"Exp. Neurol."},{"issue":"133","key":"10.1016\/j.neuint.2026.106161_bib186","article-title":"An improved method for collection of cerebrospinal fluid from anesthetized mice","author":"Lim","year":"2018","journal-title":"JoVE J."},{"key":"10.1016\/j.neuint.2026.106161_bib187","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pathol-012615-044145","article-title":"Complement dysregulation and disease: insights from contemporary genetics","volume":"12","author":"Liszewski","year":"2017","journal-title":"Annual Review of Pathology"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib188","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer's disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"issue":"46","key":"10.1016\/j.neuint.2026.106161_bib189","doi-asserted-by":"crossref","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuint.2026.106161_bib190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-5-9","article-title":"Plaque complement activation and cognitive loss in Alzheimer's disease","volume":"5","author":"Loeffler","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib191","first-page":"210","article-title":"Neuroprotective effects of resveratrol in an MPTP mouse model of parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses","volume":"17","author":"Lofrumento","year":"2011","journal-title":"Innate Immun."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib192","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"Loscher","year":"2020","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib193","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"Loscher","year":"2011","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib194","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2026.106161_bib195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib196","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol."},{"issue":"Pt 4","key":"10.1016\/j.neuint.2026.106161_bib197","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib198","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"25","key":"10.1016\/j.neuint.2026.106161_bib199","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib200","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1517\/13543784.16.12.1921","article-title":"Natural antioxidants in Alzheimer's disease","volume":"16","author":"Mancuso","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1\u20132","key":"10.1016\/j.neuint.2026.106161_bib201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","article-title":"Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process","volume":"210","author":"Mantovani","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib202","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","article-title":"Seizure-promoting effect of blood-brain barrier disruption","volume":"48","author":"Marchi","year":"2007","journal-title":"Epilepsia"},{"issue":"6A","key":"10.1016\/j.neuint.2026.106161_bib203","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1582-4934.2008.00504.x","article-title":"Complexity of complement activation in sepsis","volume":"12","author":"Markiewski","year":"2008","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib207","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2215\/CJN.06230614","article-title":"Molecules great and small: the complement system","volume":"10","author":"Mathern","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib208","first-page":"416","article-title":"Imaging tau deposits in vivo: progress in viewing more of the proteopathy picture","volume":"79","author":"Mathis","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2026.106161_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1437939","article-title":"Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications","volume":"15","author":"Mayer","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib211","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2190\/PM.43.2.e","article-title":"The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project","volume":"43","author":"McIntyre","year":"2012","journal-title":"Int. J. Psychiatr. Med."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12248","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"25","author":"McKee","year":"2015","journal-title":"Brain Pathol."},{"issue":"27","key":"10.1016\/j.neuint.2026.106161_bib213","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib214","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.168.1.458","article-title":"The membrane attack complex of complement causes severe demyelination associated with acute axonal injury","volume":"168","author":"Mead","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib216","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1007\/s00415-023-11699-x","article-title":"Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension","volume":"270","author":"Meisel","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuint.2026.106161_bib217","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib218","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib219","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib220","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib221","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000232544.90675.42","article-title":"Complement component C3 mediates inflammatory injury following focal cerebral ischemia","volume":"99","author":"Mocco","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib222","first-page":"1869","article-title":"Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation","volume":"100","author":"Mollnes","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib223","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib224","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib225","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.imbio.2015.04.006","article-title":"The membrane attack complex as an inflammatory trigger","volume":"221","author":"Morgan","year":"2016","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib226","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00281-017-0662-9","article-title":"Complement in the pathogenesis of Alzheimer's disease","volume":"40","author":"Morgan","year":"2018","journal-title":"Semin. Immunopathol."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2026.106161_bib229","series-title":"Stiehm's Immune Deficiencies","first-page":"333","article-title":"The complement system","author":"Morgan","year":"2016"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrn3200","article-title":"The ageing cortical synapse: hallmarks and implications for cognitive decline","volume":"13","author":"Morrison","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib231","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib232","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI113531","article-title":"SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis","volume":"81","author":"Murphy","year":"1988","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib233","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.165.10.5867","article-title":"Attenuation of experimental autoimmune demyelination in complement-deficient mice","volume":"165","author":"Nataf","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib234","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0166-2236(98)01390-3","article-title":"Complement anaphylatoxin receptors on neurons: new tricks for old receptors?","volume":"22","author":"Nataf","year":"1999","journal-title":"Trends Neurosci."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib235","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/neu.2007.0322","article-title":"Platelet dysfunction in patients with severe traumatic brain injury","volume":"24","author":"Nekludov","year":"2007","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib236","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol. Immunol."},{"issue":"5796","key":"10.1016\/j.neuint.2026.106161_bib237","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106161_bib238","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-5-26","article-title":"Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury","volume":"5","author":"Nguyen","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib239","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib240","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jnen\/nlw035","article-title":"Chronic repetitive mild traumatic brain injury results in reduced cerebral blood flow, axonal injury, gliosis, and increased T-tau and tau oligomers","volume":"75","author":"Ojo","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib241","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement-their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"31","key":"10.1016\/j.neuint.2026.106161_bib242","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1021\/bi034489v","article-title":"C5L2, a nonsignaling C5A binding protein","volume":"42","author":"Okinaga","year":"2003","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib243","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021338","article-title":"Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients","volume":"6","author":"Osthoff","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib244","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib245","first-page":"130","article-title":"C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis","volume":"20","author":"Papiol","year":"2019","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.neuint.2026.106161_bib246","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib247","first-page":"865","article-title":"The cholinergic anti-inflammatory pathway","volume":"26","author":"Pavlov","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib248","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajpath.2014.10.015","article-title":"Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model","volume":"185","author":"Pavlov","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib249","first-page":"103","article-title":"Expression of complement regulators and receptors on human NT2-N neurons-effect of hypoxia and reoxygenation","volume":"41","author":"Pedersen","year":"2004","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2249.2004.02489.x","article-title":"Systemic complement activation following human acute ischaemic stroke","volume":"137","author":"Pedersen","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib252","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib253","article-title":"Rodent models of amyotrophic lateral sclerosis","volume":"69","author":"Philips","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106161_bib254","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2017.00211","article-title":"NETosis in Alzheimer's disease","volume":"8","author":"Pietronigro","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Pitkanen","year":"2011","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2026.106161_bib256","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib257","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1073\/pnas.79.2.574","article-title":"Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement","volume":"79","author":"Podack","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuint.2026.106161_bib259","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuint.2026.106161_bib260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2026.106161_bib262","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.ai.2017.06.004","article-title":"Complement system in neural synapse elimination in development and disease","volume":"135","author":"Presumey","year":"2017","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib263","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajh.21319","article-title":"Generation and phenotyping of mCd59a and mCd59b double-knockout mice","volume":"84","author":"Qin","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib265","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1073\/pnas.1111924109","article-title":"C3-dependent mechanism of microglial priming relevant to multiple sclerosis","volume":"109","author":"Ramaglia","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib266","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/01.WCB.0000084250.20114.2C","article-title":"Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice","volume":"23","author":"Rancan","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib267","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.166.4.2635","article-title":"Formation of high-affinity C5 convertases of the alternative pathway of complement","volume":"166","author":"Rawal","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib268","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neulet.2016.02.025","article-title":"Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains","volume":"617","author":"Rich","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.neuint.2026.106161_bib269","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib270","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","article-title":"Complement in immune and inflammatory disorders: pathophysiological mechanisms","volume":"190","author":"Ricklin","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib272","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350816","article-title":"Complement-targeted therapeutics: are we there yet, or just getting started?","volume":"54","author":"Ricklin","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib273","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - the \"Swiss Army Knife\" of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib274","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Mol. Immunol."},{"issue":"21","key":"10.1016\/j.neuint.2026.106161_bib275","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib276","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib277","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuint.2026.106161_bib278","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fncel.2013.00253","article-title":"An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis","volume":"7","author":"Rotunno","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2026.106161_bib279","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.2","article-title":"Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene","volume":"4","author":"Ruiz","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib281","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.4049\/jimmunol.156.12.4892","article-title":"Sublytic complement attack induces cell cycle in oligodendrocytes","volume":"156","author":"Rus","year":"1996","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib282","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib283","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib284","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib285","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"issue":"Pt A","key":"10.1016\/j.neuint.2026.106161_bib286","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2017.10.012","article-title":"Status epilepticus triggers long-lasting activation of complement C1q-C3 signaling in the hippocampus that correlates with seizure frequency in experimental epilepsy","volume":"109","author":"Schartz","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib287","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4049\/jimmunol.1600280","article-title":"Structural basis for eculizumab-mediated inhibition of the complement terminal pathway","volume":"197","author":"Schatz-Jakobsen","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib288","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib289","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"17","author":"Scully","year":"2019","journal-title":"J. Thromb. Haemostasis"},{"issue":"7589","key":"10.1016\/j.neuint.2026.106161_bib290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib291","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-510X(98)00086-0","article-title":"Intrathecal activation of the complement system and disability in multiple sclerosis","volume":"157","author":"Sellebjerg","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib292","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2026.106161_bib293","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10587","article-title":"Structural basis of complement membrane attack complex formation","volume":"7","author":"Serna","year":"2016","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2026.106161_bib294","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2004.06.003","article-title":"Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist","volume":"155","author":"Sewell","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2016.03.002","article-title":"Heterogeneous MAC initiator and pore structures in a lipid bilayer by phase-plate cryo-electron tomography","volume":"15","author":"Sharp","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib296","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","article-title":"Complement activation by neurofibrillary tangles in Alzheimer's disease","volume":"305","author":"Shen","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib297","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-9158-2-21","article-title":"What does complement do in Alzheimer's disease? Old molecules with new insights","volume":"2","author":"Shen","year":"2013","journal-title":"Transl. Neurodegener."},{"issue":"392","key":"10.1016\/j.neuint.2026.106161_bib299","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"38","key":"10.1016\/j.neuint.2026.106161_bib300","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","article-title":"Complement C3-deficient mice fail to display age-related hippocampal decline","volume":"35","author":"Shi","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib301","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64604-4","article-title":"Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis","volume":"157","author":"Singhrao","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib303","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib304","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","article-title":"Chronic neuropathologies of single and repetitive TBI: substrates of dementia?","volume":"9","author":"Smith","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib305","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12017-008-8037-y","article-title":"Hormetic dietary phytochemicals","volume":"10","author":"Son","year":"2008","journal-title":"NeuroMolecular Med."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib306","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000449","article-title":"Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis","volume":"30","author":"Spatola","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib307","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","article-title":"Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mechanisms of Ageing and Development"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib308","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"3\u20134","key":"10.1016\/j.neuint.2026.106161_bib310","first-page":"263","article-title":"The role of the complement system in brain injury","volume":"16","author":"Stahel","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib311","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib312","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","article-title":"The concept of alpha-synuclein as a prion-like protein: ten years after","volume":"373","author":"Steiner","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuint.2026.106161_bib313","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"33","key":"10.1016\/j.neuint.2026.106161_bib314","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","article-title":"A dramatic increase of C1q protein in the CNS during normal aging","volume":"33","author":"Stephan","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib315","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib316","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/brain\/aww314","article-title":"Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia","volume":"140","author":"Stokowska","year":"2017","journal-title":"Brain"},{"issue":"5\u20136","key":"10.1016\/j.neuint.2026.106161_bib317","first-page":"244","article-title":"Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome","volume":"47","author":"Stokowska","year":"2019","journal-title":"Cerebrovasc. Dis."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib318","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","article-title":"Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination","volume":"43","author":"Storch","year":"1998","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib319","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib321","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni.2499","article-title":"Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-\u03b21 signaling and induction of Foxp3+ regulatory T cells","volume":"14","author":"Strainic","year":"2013","journal-title":"Nat. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.neuint.2026.106161_bib322","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib323","first-page":"626","article-title":"Complement inhibition alleviates paraquat-induced acute lung injury","volume":"51","author":"Sun","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib325","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2008.07.044","article-title":"Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes","volume":"204","author":"Szeplaki","year":"2009","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.neuint.2026.106161_bib326","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib327","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2026.106161_bib328","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib329","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12026-011-8239-5","article-title":"Membrane attack by complement: the assembly and biology of terminal complement complexes","volume":"51","author":"Tegla","year":"2011","journal-title":"Immunol. Res."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib330","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/01.STR.0000182237.20807.d0","article-title":"C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice","volume":"36","author":"Ten","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib331","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-mediated events in Alzheimer's disease: mechanisms and potential therapeutic targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib332","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1523\/JNEUROSCI.0399-12.2013","article-title":"Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury","volume":"33","author":"Tep","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib333","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","article-title":"Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment","volume":"59","author":"Thambisetty","year":"2012","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib334","first-page":"2197","article-title":"Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica","volume":"26","author":"Tradtrantip","year":"2012","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14737175.2017.1244482","article-title":"Targeting mTOR to reduce alzheimer-related cognitive decline: from current hits to future therapies","volume":"17","author":"Tramutola","year":"2017","journal-title":"Expert Rev. Neurother."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib336","first-page":"78","article-title":"Immunohistological alterations in muscle of patients with amyotrophic lateral sclerosis: mononuclear cell phenotypes and expression of MHC products","volume":"9","author":"Troost","year":"1990","journal-title":"Clin. Neuropathol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib337","first-page":"11","article-title":"Clusterin: modulation of complement function","volume":"97","author":"Tschopp","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"46","key":"10.1016\/j.neuint.2026.106161_bib339","first-page":"E4385","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"109","author":"Tschopp","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib342","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00467-19","article-title":"Nrf2 suppresses oxidative stress and inflammation in App knock-in Alzheimer's disease model mice","volume":"40","author":"Uruno","year":"2020","journal-title":"Mol. Cell Biol."},{"issue":"22","key":"10.1016\/j.neuint.2026.106161_bib343","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.97.22.2259","article-title":"Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy","volume":"97","author":"Vakeva","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib344","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/exnr.1999.7273","article-title":"Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse","volume":"161","author":"van Beek","year":"2000","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.neuint.2026.106161_bib345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib346","first-page":"655","article-title":"Complement C5 contributes to brain injury after subarachnoid hemorrhage","volume":"11","author":"van der Jagt","year":"2020","journal-title":"Translational Stroke Research"},{"issue":"Pt 2","key":"10.1016\/j.neuint.2026.106161_bib347","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib348","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0297-16.2016","article-title":"Temporary depletion of microglia during the early postnatal period induces lasting sex-dependent and sex-independent effects on behavior in rats","volume":"3","author":"VanRyzin","year":"2016","journal-title":"eNeuro"},{"issue":"14","key":"10.1016\/j.neuint.2026.106161_bib349","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.neuint.2026.106161_bib350","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/01.wnl.0000174472.03292.dd","article-title":"SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS","volume":"65","author":"Veldink","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2026.106161_bib351","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib353","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib354","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nprot.2015.002","article-title":"Quantitative assessment of angiogenesis, perfused blood vessels and endothelial tip cells in the postnatal mouse brain","volume":"10","author":"W\u00e4lchli","year":"2015","journal-title":"Nat. Protoc."},{"issue":"6478","key":"10.1016\/j.neuint.2026.106161_bib355","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.aaz2288","article-title":"Microglia mediate forgetting via complement-dependent synaptic elimination","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106161_bib356","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.02.005","article-title":"Astrocyte-secreted C3 signaling impairs neuronal development and cognition in autoimmune diseases","volume":"545","author":"Wang","year":"2024","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuint.2026.106161_bib358","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","article-title":"Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease","volume":"18","author":"Webster","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib359","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0002-9440(10)63466-9","article-title":"Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis","volume":"163","author":"Weerth","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib361","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington's disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106161_bib362","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-neuro-070918-050306","article-title":"Neuron-glia signaling in synapse elimination","volume":"42","author":"Wilton","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"issue":"14","key":"10.1016\/j.neuint.2026.106161_bib364","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5-C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuint.2026.106161_bib367","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3389\/fneur.2017.00700","article-title":"Status epilepticus triggers time-dependent alterations in microglia abundance and morphological phenotypes in the hippocampus","volume":"8","author":"Wyatt-Johnson","year":"2017","journal-title":"Front. Neurol."},{"issue":"16","key":"10.1016\/j.neuint.2026.106161_bib368","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib369","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","article-title":"Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities","volume":"21","author":"Xiong","year":"2018","journal-title":"Chin. J. Traumatol. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"20","key":"10.1016\/j.neuint.2026.106161_bib371","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease","volume":"20","author":"Yang","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2026.106161_bib372","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Up-regulated production and activation of the complement system in Alzheimer's disease brain","volume":"154","author":"Yasojima","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.neuint.2026.106161_bib373","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-\u03baB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib374","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","article-title":"Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice","volume":"24","author":"Yilmaz","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuint.2026.106161_bib375","first-page":"1199","article-title":"Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4","volume":"29","author":"You","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib376","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.neuint.2026.106161_bib377","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","article-title":"Complement activation in very early Alzheimer disease","volume":"19","author":"Zanjani","year":"2005","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuint.2026.106161_bib378","article-title":"The complement system in neurodegenerative and inflammatory diseases of the central nervous system","volume":"15","author":"Zelek","year":"2024","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib379","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","article-title":"Regulation of toll-like receptor-mediated inflammatory response by complement in vivo","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"issue":"50","key":"10.1016\/j.neuint.2026.106161_bib380","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","article-title":"Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.neuint.2026.106161_bib381","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuint.2026.106161_bib382","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molimm.2015.03.012","article-title":"The role of complement in C3 glomerulopathy","volume":"67","author":"Zipfel","year":"2015","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.neuint.2026.106161_bib383","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:19:52Z","timestamp":1778271592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018626000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":352,"alternative-id":["S0197018626000525"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106161","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106161"}}